<?xml version="1.0" encoding="UTF-8"?>
<p>4-(4-(1-(2-Trifluoromethyl-benzyl)-1H-indol-3-yl)butanamido)-N-hydroxybenzamide (
 <bold>I5</bold>). HRMS (AP-ESI) 
 <italic>m/z</italic> calcd for C
 <sub>27</sub>H
 <sub>24</sub>F
 <sub>3</sub>N
 <sub>3</sub>O
 <sub>3</sub> [M + H]
 <sup>+</sup> 496.18033, found 496.18295. 
 <sup>1</sup>H NMR (400 MHz, DMSO) 
 <italic>δ</italic> 11.08 (s, 1H), 10.11 (s, 1H), 8.93 (s, 1H), 7.80 (d, 
 <italic>J</italic> = 6.9 Hz, 1H), 7.71–7.61 (m, 5H), 7.52–7.45 (m, 2H), 7.29 (s, 1H), 7.18 (d, 
 <italic>J</italic> = 8.0 Hz, 1H), 7.12–7.03 (m, 2H), 6.52 (d, 
 <italic>J</italic> = 7.0 Hz, 1H), 5.58 (s, 2H), 2.79 (t, 
 <italic>J</italic> = 7.6 Hz, 2H), 2.43 (t, 
 <italic>J</italic> = 7.2 Hz, 2H), 2.04–1.97 (m, 2H); 
 <sup>13</sup>C NMR (400 MHz, DMSO): 
 <italic>δ</italic> = 172.04, 164.41, 142.35, 137.40, 136.65, 133.48, 128.35, 128.26, 128.13, 127.80, 127.39, 127.12, 126.36, 123.58, 122.12, 119.46, 119.36, 118.74, 115.12, 110.04, 45.95, 36.63, 26.16, 24.61 ppm.
</p>
